PHENYL UREA DERIVATIVE

The present invention pertains to a therapeutic agent or preventative agent against diseases involving an orexin receptor, particularly an orexin type-2 receptor, the agent containing a novel compound having a urea skeleton, or a pharmacologically acceptable salt thereof, as an active ingredient. Sp...

Full description

Saved in:
Bibliographic Details
Main Authors FUNAKOSHI Yuta, LEE Shoukou, TANAKA Daisuke, KOMIYA Masafumi, IDEUE Eiji, UESUGI Shunichiro
Format Patent
LanguageEnglish
Spanish
Published 11.12.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention pertains to a therapeutic agent or preventative agent against diseases involving an orexin receptor, particularly an orexin type-2 receptor, the agent containing a novel compound having a urea skeleton, or a pharmacologically acceptable salt thereof, as an active ingredient. Specifically, the present invention pertains to a therapeutic agent or preventative agent against diseases such as narcolepsy, idiopathic hypersomnia, hypersomnia, and sleep apnea syndrome. La presente invención se refiere a un medicamento para tratar o prevenir una enfermedad relacionada con receptor de orexina, especialmente receptor de orexina tipo 2, que comprende un nuevo compuesto que tiene una estructura de urea o una sal farmacéuticamente aceptable de la misma como un ingrediente activo; en más detalle, la presente invención se refiere a un medicamento para tratar o prevenir una enfermedad tal como narcolepsia, hipersomnia idiopática, hipersomnia, síndrome de apnea del sueño.
Bibliography:Application Number: MX20230013975